Promising research on cancer treatment was presented in Munich

The technology of casein kinase 1 inhibitors from MUNI laboratories was presented by TTO on May 8 and 9 at the BioVaria conference in Munich. Potential investors could learn more about the promising research that could help fight leukemia and other types of cancer. TTO is seeking for partners who will help to move this interesting project a step further. At the conference, the technology was presented in the form of a poster on a stand with the Prague IOCBTech by our business manager Jana Daňková.